IPF Patents Research (17)
17 papers in the IPF Patents topic, indexed by PF-Atlas from PubMed and global journals.
- Global landscape for pulmonary fibrosis treatment: a data-driven perspective from clinical trials. · BMC pulmonary medicine · 2026
- Jinbei oral liquid for idiopathic pulmonary fibrosis: a randomized placebo-controlled trial · Scientific Reports · 2025
- Adverse side-effects of antifibrotic drugs and outcome of treatment in idiopathic pulmonary fibrosis · Journal of Thoracic Disease · 2025
- Lactiplantibacillus sp. LP03 alleviates pulmonary fibrosis by modulating gut microbiota and elevating host palmitoylethanolamide to suppress TGF-β1/Smad2/3-mediated EMT · Frontiers in Microbiology · 2025
- Formononetin-Loaded PLGA Large Porous Microparticles via Intratracheal Instillation for Bleomycin-Induced Pulmonary Fibrosis Treatment · AAPS PharmSciTech · 2025
- Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis. · The New England journal of medicine · 2025
- Monomeric compounds from natural products for the treatment of pulmonary fibrosis: a review · Inflammopharmacology · 2024
- Xuanfei Baidu decoction ameliorates bleomycin-elicited idiopathic pulmonary fibrosis in mice by regulating the lung-gut crosstalk via IFNγ/STAT1/STAT3 axis. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2024
- The dual role of 20 -protopanaxadiol in alleviating pulmonary fibrosis through the gut-lung axis. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2024
- Pirfenidone and Nintedanib in Pulmonary Fibrosis: Lights and Shadows · Pharmaceuticals · 2024
- Tetrahedral Framework Nucleic Acids Delivery of Pirfenidone for Anti-Inflammatory and Antioxidative Effects to Treat Idiopathic Pulmonary Fibrosis. · ACS nano · 2024
- Regulation effect of the intestinal flora and intervention strategies targeting the intestinal flora in alleviation of pulmonary fibrosis development · Bioscience of Microbiota, Food and Health · 2024
- Network Pharmacology and Machine Learning Reveal Salidroside’s Mechanisms in Idiopathic Pulmonary Fibrosis Treatment · Journal of Inflammation Research · 2024
- The role of biomarkers in the diagnosis and treatment follow-up of idiopathic pulmonary fibrosis · Sarcoidosis, Vasculitis, and Diffuse Lung Diseases · 2024
- Network pharmacology and molecular docking combined with widely targeted metabolomics to elucidate the potential compounds and targets of Euphorbia helioscopia seeds for the treatment of pulmonary fibrosis · Computers in biology and medicine · 2023
- I-PreFer Study: A Questionnaire to Explore Patient, Caregiver and Pulmonologist Preferences of Idiopathic Pulmonary Fibrosis Treatment Options · Patient preference and adherence · 2023
- Inhalation of Tetrandrine- hydroxypropyl-β-cyclodextrin Inclusion Complexes for Pulmonary Fibrosis Treatment. · Molecular pharmaceutics · 2020
Medical disclaimer. Research listings are for information only and are not medical advice.